Pathogenetic aspects of the use of cytoflavine in the treatment of сhronic post-traumatic headache

Close metadata

Recommended articles:

The association of polymorphisms of the serotonin transporter gene SLC6A4 with depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(2):135-139

The effect of insomnia on mild cognitive impairment in patients with vascular risks: results of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36

A perspective on the application of CRISPR/CAS9 genome editing system to study of molecular-genetic basis of mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33

Asthenic disorders correction with Recognan. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):57-62

Factors of the hemostasis system as biomarkers of severe course of acute viral infections. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):63-74

Validation of screening method based on EEG analysis for the risk assessment of psychiatric and behavioral disorders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96

A clinical case of the new-onset bipolar affective disorder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129

Features of the clinical picture of affective disorders in women during the menopausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79

Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30

Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137

Objective. To evaluate the results of using cytoflavin in the treatment of chronic post-traumatic headache and analyze possible mechanisms for implementation of therapeutic effects of the drug. Material and methods. The study included 76 patients (23 men and 53 women) aged 29 - 57 years (mean age – 38.2 ± 8.3). All patients received standard basic therapy with simple or combination analgesics. In addition to standard treatment, 36 patients received cytoflavin in the dosage of two tablets twice a day for 30 days. Results and сonclusion. At the beginning, at the end and 25 days after the completion of treatment, the intensity and frequency of headache as well as the severity of asthenic and depressive symptoms were analyzed. As a result of treatment in the cytoflavin group, there was a significant regression of asthenic and depressive symptoms, which was consistent with the previous studies. Positive changes in the indicators analyzed were correlated with the decrease in the frequency of cephalalgia. Since cytoflavin has no analgesic properties, the results are indirect evidence for the significance of psychopathological factors in the pathogenesis of chronic post-traumatic headache.

Keywords:

chronic post-traumatic headache

asthenia

depression emotional

cytoflavin

Authors:

Iskra D.A.

Kirov Military Medical Academy, Saint-Petersburg, Russia

List of references:

Odinak MM, Iskra DA. Sistematizacija pervichnyh golovnyh bolej: blizhajshie i otdalennye perspektivy. Voenno-medicinskij zhurnal. 2014;335(2):22-31. (In Russ.).
Formisano R, Bivona U, Catani S, D’Ippolito M, Buzzi G. Post-traumatic headache: facts and doubts. J Headache Pain. 2009;10(3):145-152. doi: 10.1007/s10194-009-0108-4
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi: 10.1177/0333102413485658
Martins HA, Ribas VR, Martins BB, Ribas R de M, Valença MM. Post-traumatic headache. Arq Neuropsiquiatr. 2009;67(1):43-45. doi: 0.1590/S0004-282X2009000100011
Solomon S. Post-traumatic headache: commentary: an overview. Headache. 2009;49(7):1112-1115. doi: 10.1111/j.1526-4610.2009.01462.x
Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: A systematic review. JAMA. 2008;300(6):711-719. doi: 10.1001/jama.300.6.711
Sheftell FD, Tepper SJ, Lay CL, Bigal ME. Post-traumatic headache: Emphasis on chronic types following mild closed head injury. Neurol Sci. 2007;28(S2):203-207. doi: 10.1007/s10072-007-0777-1
Yang CC, Hua MS, Tu YK, Huang SJ. Early clinical characteristics of patients with persistent post-concussion symptoms: A prospective study. Brain Inj. 2009;23(4): 299-306. doi: 10.1080/02699050902788543
Couch JR, Lipton RB, Stewart WF, Scher AI. Head or neck injury increases the risk of chronic daily headache: A population-based study. Neurology. 2007;69(11):1169-1177. doi: 10.1212/01.wnl.0000276985.07981.0a
Obermann M, Nebel K, Schumann C, Holle D, Gizewski ER, Maschke M, Goadsby PJ, Diener H-C, Katsarava Z. Gray matter changes related to chronic posttraumatic headache. Neurology. 2009;73(12):978-983. doi: 10.1212/WNL.0b013e3181b8791a
Stovner LJ, Schrader H, Mickeviciene D, Surkiene D, Sand T. Headache after concussion. Eur J Neurol. 2009;16(1):112-120. doi: 10.1111/j.1468-1331.2008.02363.x
Lenaerts ME. Post-traumatic headache: from classification challenges to biological underpinnings. Cephalalgia. 2008;28(1):(suppl):12-15. doi: 10.1111/j.1468-2982.2008.01608.x
Polunina AG, Osinovskaja NA, Gudkova AN, Geht AB. Vlijanie citoflavina na simptomy astenii, jemocional'noe sostojanie i vegetativnuju reguljaciju u pacientov s organicheskim astenicheskim rasstrojstvom. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114(2):28-32. (In Russ.).
Skoromec AA, Pugacheva EL. Issledovanie jeffektivnosti kompleksnogo preparata citoflavin dlja korrekcii posledstvij legkoj cherepno-mozgovoj travmy. Poliklinika. 2011;5(1):50-54. (In Russ.).
Suslina ZA, Rumjanceva CA, Tanashjan MM, Skoromec AA, Klocheva EG, Fedin AI, Kovalenko AL, Silina AV, Sholomov II. Kompleksnaja jenergokorrekcija hronicheskoj ishemii mozga. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2011;111(3):25-39. (In Russ.).

Close metadata